Carbazole derivative, solvate thereof, or pharmaceutically acceptable salt thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8329913
APP PUB NO 20100286210A1
SERIAL NO

11666631

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

An object of the present invention is to provide novel carbazole derivatives, solvates thereof, or pharmaceutically acceptable salts thereof having an excellent adipose tissue weight reducing effect, hypoglycemic effect, and hypolipidemic effect, which are useful as a preventive and/or therapeutic agent for fatty liver, obesity, lipid metabolism abnormality, visceral adiposity, diabetes, hyperlipemia, impaired glucose tolerance, hypertension, non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, and the like.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ZERIA PHARMACEUTICAL CO LTD10-11 NIHONBASHI KOBUNA-CHO CHUO-KU TOKYO 1038351 ?1038351

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Itokazu, Yoshihiko Tokyo, JP 1 102
Murata, Masakazu Tokyo, JP 38 403
Nakao, Ryu Tokyo, JP 8 115

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation